Navigation Links
Dapagliflozin in Medical Technology

First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes

-- Additional Findings Reported on Glucose Homeostasis Effects in Normal and Diabetic Rats -- CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- In a 14-day, Phase IIa study of the safety profile of multiple doses of the investigational compound dapagliflozin, a selective inhibitor of the Sodium-Glu...
Dapagliflozin in other areas

Dapagliflozin - Wikipedia, the free encyclopedia

Dapagliflozin (rINN/USAN) is an experimental drug being studied by Bristol-Myers Squibb in partnership with AstraZeneca as a potential treatment for type 1 and 2 diabetes. Although dapagliflozin's method of action would...

AZN,BMY Dapagliflozin Study Demonstrated Improved Glycemic Control In ...

TradingMarkets News for AZN,BMY - Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and ...

Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 ...

PRINCETON, N.J. & WILMINGTON, Del.--(BUSINESS WIRE)--Results from a 12-week study demonstrated that the investigational drug dapagliflozin, a novel, selective,

News: Dapagliflozin Study Demonstrated Improved Glycemic Control In ...

Results from a 12-week study demonstrated that the investigational drug dapagliflozin, a novel, selective, sodium glucose co-transporter 2 (SGLT2) inhibitor, ...

Type 2 Diabetes Patients Treated With Dapagliflozin Show Dose-Dependent ...

Dapagliflozin, a highly selective inhibitor of sodium glucose co-transporter 2 ... Patients were randomised to dapagliflozin (2.5, 5, 10, 20, or 50 mg/day) ...

reportonbusiness.com: globeinvestor.com - Dapagliflozin Study ...

Overall adverse events across the dapagliflozin treatment arms were reported at ... Dapagliflozin is an investigational SGLT2 inhibitor currently in Phase 3 trials ...
Other Tags
(Date:10/29/2014)... certain prostate cancer medications are linked with an increased ... congestive heart failure or prior heart attacks. Published in ... and patients weigh the benefits and risks of the ... levels of male hormones in the body to prevent ... treatment for prostate cancer. Despite its anticancer effects, ADT ...
(Date:10/28/2014)... that aims to make personalized medicine a reality for ... across British Columbia. , The "Genomics for Precision Drug ... of its kind in North America. The project is ... (BCPhA), with the research component led by a team ... Sciences (UBC). It will position the pharmacist as the ...
(Date:10/28/2014)... Uppsala University demonstrate that elderly men with self-reported ... Alzheimer,s disease than men without self-reported sleep disturbances. ... Alzheimer,s & Dementia . , The researchers ... 50 year old, between the years 1970 and ... self-reported sleep disturbances were linked to an increased ...
(Date:10/27/2014)... from Massachusetts General Hospital (MGH) investigators has identified ... activity of a key brain region in patients ... a mechanism of action behind one of the ... therapy. They also found evidence that pretreatment ... which patients are likely to respond to that ...
(Date:10/27/2014)... adopt a new therapy by watching others use it, ... , New technology is like an influential colleague -- ... reminded every five to seven days , CHICAGO ... when they are persuaded to do so by an influential ... adopting innovations also have relevance for business, education and research. ...
Breaking Medicine News(10 mins):Health News:Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems 2Health News:Genomics helps pharmacists target the right drugs for the right patient 2Health News:PET scans reveal how psychodynamic therapy for depression may change brain function 2Health News:PET scans reveal how psychodynamic therapy for depression may change brain function 3Health News:Persuading doctors to quickly adopt new treatments 2Health News:Persuading doctors to quickly adopt new treatments 3
(Date:10/29/2014)... by the international Cancer Genomics of the Kidney ... between kidney cancer and exposure to aristolochic acid, ... published in Nature Communications , have important ... more than 140,000 people every year, and in ... CAGEKID, part of the International Cancer Genome Consortium ...
(Date:10/28/2014)... have published a paper in the Proceedings of ... details about key transitions in the evolution of plant ... mosses, ferns, trees and flowers growing deep in steamy ... the ornamental plants adorning our homes, all plant life ... "Our study generated DNA sequences from a vast number ...
(Date:10/28/2014)... be building a hybrid micro-grid which will integrate ... in the region, the hybrid micro-grid will test ... diesel, storage and power-to-gas technologies, and ensure these ... built under the new Renewable Energy Integration Demonstrator- ... located offshore at Semakau Landfill and is expected ...
Breaking Biology News(10 mins):Kidney cancer in Central Europe 2New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3
Other Contents